Putative Probiotic Strains Isolated from Kefir Improve Gastrointestinal Health Parameters in Adults: a Randomized, Single-Blind, Placebo-Controlled Study

Ming-Cheng Wang,Ahmad Imran Zaydi,Wei-Hung Lin,Jin-Seng Lin,Min-Tze Liong,Jiunn-Jong Wu
DOI: https://doi.org/10.1007/s12602-019-09615-9
2019-11-20
Probiotics and Antimicrobial Proteins
Abstract:The dairy products remain as the largest reservoir for isolation of probiotic microorganisms. While probiotics have been immensely reported to exert various health benefits, it is also a common notion that these health potentials are strain and host dependent, leading to the need of more human evidence based on specific strains, health targets, and populations. This randomized, single-blind, and placebo-controlled human study aimed to evaluate the potential benefits of putative probiotic strains isolated from kefir on gastrointestinal parameters in fifty-six healthy adults. The consumption of AB-kefir (<i>Bifidobacterium longum</i>, <i>Lactobacillus acidophilus</i>, <i>L. fermentum</i>, <i>L. helveticus</i>, <i>L. paracasei</i>, <i>L. rhamnosus</i>, and <i>Streptococcus thermophiles</i>; total 10 log CFU/sachet) daily for 3 week reduced symptoms of abdominal pain, bloating (<i>P</i> = 0.014), and appetite (<i>P</i> = 0.041) in male subjects as compared to the control. Gut microbiota distribution profiles were shifted upon consumption of AB-kefir compared to baseline, where the abundance of bifidobacteria was increased in male subjects and maintained upon cessation of AB-kefir consumption. The consumption of AB-kefir also increased gastrointestinal abundance of total anaerobes (<i>P</i> = 0.038) and total bacterial (<i>P</i> = 0.049) in female subjects compared to the control after 3 weeks. Our results indicated that AB-kefir could potentially be developed as a natural strategy to improve gastrointestinal functions in adults.
biotechnology & applied microbiology,microbiology
What problem does this paper attempt to address?